cities 2 A variety of stress responses in cells will be produced when various external stimuli (various carcinogenic factors) act on breast epithelial cells, resulting in cell proliferation, thus leading to breast cancer 3 At present, surgical operation is dominated in the clinical treatment approaches of breast cancer, but the range of surgical resection in clinic is wide, the trauma is large, and a lot of related complications often occur in patients after clinical surgical treatment, causing serious physiological and psychological damage to patients 4 .
A large number of studies in recent years have revealed that various specific gene mutations were identified in tumor patients and several microribonucleic acids (miRNAs) are closely related to the tumor metastasis and invasion 5, 6 Osipov et al 7 found high expression of miR-205 in epithelial ovarian cancer cells, indicating that miR-205 is possibly associated with the incidence of ovarian cancer. There is a great amount of research evidence proving that the miR-205 expressions in a variety of tumors are lower than that in normal tissues [8] [9] [10] [11] miRNAs are therefore applied in the diagnosis of cancer 12, 13 For instance, miR-205 presents as the potential biomarkers for early prognosis or diagnosis while its level is proposed in predicting lymph node metastasis in triple-negative breast cancer patients 14, 15 Moreover, it has been demonstrated that miR-205/ASPP2 axis promoted cell migration and also increased cell proliferation, which may be potential diagnostic and therapeutic biomarkers in cervical and lung cancers 16 miR-205 enhances chemosensitivity of breast cancer cells to TAC chemotherapy by suppressing both VEGFA and FGF2, leading to evasion of apoptosis 17 However, the exact role of miR-205-3p in the pathogenesis and development of breast cancer remains poorly understood. The present study aims to investigate the role and possible mechanism of miR-205-3p in breast cancer, in order to provide a theoretical basis for further elaborating the effect of miR-205-3p in the course of breast cancer.
| PATIENTS AND ME THODS

| Patients and grouping
A total of 58 patients who were pathologically diagnosed with breast cancer, treated, and underwent mastectomy in Guangdong Provincial People's Hospital from June 2011 to June 2013 were collected. None of the patients received chemotherapy and radiotherapy before operation. The para-carcinoma tissues of breast cancer (more than 5 cm away from the breast cancer tissues) were taken during operation as the control. All enrolled patients were females aged 42-69 years with a median age of 56.2 years, and they all suffered from invasive ductal carcinoma. According to the tumor-node-
metastasis (TNM) staging criteria issued by the International Union
Against Cancer, patients were staged, and there were 8 cases in stage I, 41 cases in stage II, 6 cases in stage III, and 3 cases in stage IV. Inclusion criteria were as follows: (1) patients without severe hepatic and renal function impairment, (2) patients who agreed to be followed up, (3) patients without a history of serious cardiovascular and immune system diseases, and (4) patients without chronic or acute infectious diseases. All enrolled patients personally signed the informed consent and had complete clinical and pathological data and complete therapeutic regimens. The experimental scheme was reviewed and approved ethically by our hospital.
| Detection of miR-205-3p expression level in breast cancer tissues
After breast cancer tissues and para-carcinoma tissues were obtained, they were added into the tube (100 mg/mL) together with TRIzol, and smashed using an ultrasonic disruptor followed by being incubated on ice for 10 minutes, followed by centrifugation at 12 000 g and 4°C for 10 minutes. 700 μL supernatant was taken, added with chloroform, and manually vibrated for 10 times, followed by incubation on ice for 10 minutes and centrifugation at 12 000 g and 4°C for 10 minutes. After the supernatant was discarded, 1 mL freshly prepared 75% ethanol was added into each tube, followed by centrifugation at 12 000 g and 4°C for 15 minutes. The ethanol was discarded, the cap of the centrifuge tube was removed for natural air-drying, and 30 μL diethyl pyrocarbonate (DEPC)-treated water was added to dissolve the RNA. The optical density (OD) value and purity of RNA were measured. The reaction system was prepared strictly according to instructions of the reverse transcription kit (Invitrogen): 5 μg total RNA, 1 μL Oligo(dT) 20 , 1 μL 10 mmol/L dNTP, and 3 μL 0.1mol/L DTT were added, and DEPC-treated water was also added until the total volume was 20 μL. After reaction at 60°C for 15 minutes and incubation at 37°C for 2 minutes, the reverse transcription was performed. After RT-qPCR system was prepared, the amplification was performed on the RT-qPCR instrument.
Amplification conditions are as follows: pre-denaturation at 92°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, extension at 72°C for 2 minutes, and a total of 35 cycles. Primers were synthesized by Invitrogen, and RNU6B was used as the internal control. The primer sequence was as follows: 5′-CGG GAT TTC AGT GGA GTG AAG TTC-3′ (miR-205-3p); 5′-CTC GCT TCG GCA GCA CA-3′ (RNU6B, sense) and 5′-AAC GCT TCA CGA ATT TGC GT-3′ (RNU6B, antisense). The expression of miR-205-3p was quantified as a relative expression to RNU6B using 2 −△△ CT method. All RT-qPCR experiments were conducted according to the MIQE (minimum information for publication of quantitative real-time PCR experiments) guidelines 18 Each amplification reaction was performed in triplicate, and mean value of the three-cycle threshold was used for further analysis. Based on the median expression of miR-205-3p, patients were further divided into high and low expression group.
| Survival curve analysis
The miR-205-3p expression in cancer tissues of each patient with breast cancer was detected and compared with that in para-carcinoma tissue, and divided into normal or low expression group and high expression group. Data of patients were recorded in detail, and patients were followed up for 5 years. The 5-year survival rate of patients was recorded, and the survival curve was drawn. Influencing factors of patient's prognosis in both groups were analyzed via Cox multivariate regression analysis.
| Cell culture and construction of cell lines with miR-205-3p overexpression
Human breast cancer MCF-7 cell lines were purchased from the Kunming Cell Bank of the Chinese Academy of Sciences. After resuscitation, cells were cultured using Dulbecco's modified Eagle medium (DMEM) (Gibco) containing 10% fetal bovine serum (FBS) in an incubator with 5% CO 2 at 37°C till the logarithmic growth phase.
Then, cells were digested with trypsin and continued to be cultured, followed by passage till the 3rd generation used for the experiment. 
| Detection of cell proliferation and invasion capacities
Cell proliferation capacity was detected via methyl thiazolyl tetrazolium (MTT) assay: After cells in the logarithmic growth phase were digested, the cell density was adjusted to 1 × 10 4 /well, and cells were inoculated into a 96-well plate and divided into blank control group (MCF-7 cells without any treatment), negative control group (MCF-7cells inoculated with empty vector), and hsa-miR-205-3p group (MCF-7 cells inoculated with hsa-miR-205-3p), followed by culture in an incubator for 24 hours. Then, 100 μL MTT was added to culture cells for another 4 hours, the supernatant was discarded, and 150 μL dimethyl sulfoxide (DMSO) was added into each well and vibrated on a shaking table for 1 minute. Finally, cell proliferation in each group was detected using a microplate reader.
Cell invasion capacity was detected via transwell assay: After
cells in the logarithmic growth phase were digested, the cell density was adjusted to 1.5 × 10 6 /well, and the cell suspension was pre- Then, the cell suspension was inoculated into a 6-well plate and added with serum-free DMEM, followed by culture in the incubator for 24 hours. After the culture solution was discarded, cells were washed with phosphate-buffered saline (PBS), scraped off, centrifuged, and resuspended with PBS for 3 times strictly according to instructions of the apoptosis kit (BD Bioscience). The fluorescence maker was added and cells were incubated in a dark place at room temperature for 15 minutes, followed by sample loading and detection via flow cytometry. All samples should be detected within 1 hour to ensure the effect.
| Detection of apoptosis
| Detection of expression levels of related proteins
Cells in each group were cultured in the 6-well plate, collected, followed by addition of radioimmunoprecipitation assay (RIPA) lysis solution (Wuhan Servicebio) and 1% protease inhibitor (Wuhan Servicebio) into each well (500 μL/well). After breast cancer tissues and para-carcinoma tissues were obtained, they were added with RIPA lysis solution and 1% protease inhibitor (100 mg/mL) and smashed using the ultrasonic disruptor. The above cell suspension and tissue homogenate were incubated on ice, followed by centrifugation at 1000 g and 4°C for 10 minutes to obtain the total protein solution. The total protein concentration in each sample was detected using the BCA protein assay kit (PIERCE). After the protein loading buffer in an equal concentration was prepared, 10% gel was prepared and added with an equal amount of loading buffer, followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis under constant pressure. Then, the protein was transferred onto a PVDF membrane (Millipore), and the target band was cut and sealed with freshly prepared 5% skim milk powder for 2 hours. Ezrin, LaminA/C, cleaved caspase-3, Bcl-2, Bax, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies (purchased from CST, USA, and prepared at a volume ratio of 1:1000) were incubated at 4°C over- 
| Statistical analysis
In this study, three independent experiments were performed for in vitro assay. Data were presented as mean ± SD and processed using 
| RE SULTS
| miR-205-3p expression in breast cancer tissues
The miR-205-3p expressions in tumor tissues and para-carcinoma tissues of breast cancer patients were detected via RT-qPCR.
According to results, the miR-205-3p expression in tumor tissues of breast cancer patients was increased significantly compared with that in para-carcinoma tissues (1.87 ± 0.63 vs 1, P < 0.01) ( Figure 1 ).
| Related protein expressions in breast cancer tissues
Ezrin, LaminA/C, cleaved caspase-3, Bcl-2, and Bax protein expressions in tumor tissues and para-carcinoma tissues of breast cancer patients were detected via Western blotting. Results manifested that compared with those in para-carcinoma tissues, Ezrin, LaminA/C, and cleaved caspase-3 expressions were significantly declined in tumor tissues (P < 0.01), but the Bcl-2/Bax ratio was increased significantly (P < 0.01) ( Figure 2 ).
| Correlations of miR-205-3p with clinicopathological features of breast cancer patients
The miR-205-3p level was classified as high or low in relation to the median value (cutoff value = 1.704). The above patients were accordingly divided into low or normal expression group and high expression group based on the miR-205-3p expression level in breast cancer tissues, with para-carcinoma tissues as the control. The clinicopathological data of patients in each group were recorded in details, and correlations of miR-205-3p expression level with clinicopathological data of patients were analyzed. Results showed that miR-205-3p was not related to the age and menstrual condition of breast cancer patients, but statistically closely related to the size, TNM staging, lymph node metastasis, and recurrence of breast cancer (P < 0.05) ( Table 1) .
Further univariate and multivariate analysis showed that miR-205-3p expression was an independent factor for the survival (recurrence-free survival) of breast cancer patients ( Table 2 ).
| Correlation of miR-205-3p with prognosis of breast cancer patients
All breast cancer patients enrolled were followed up for 5 years, the survival rate of patients was recorded, and the survival curve was drawn. According to results, the 5-year survival rate of breast cancer patients with low or normal expression of miR-205-3p was significantly higher than that in patients with high expression of miR-205-3p (P < 0.01) (Figure 3 ).
| Construction of cell lines with miR-205-3p overexpression
After human breast cancer MCF-7 cells were transfected with miR-205-3p lentivirus, the miR-205-3p expression in each group was detected via RT-qPCR. Results showed that miR-205-3p expression levels in cells in blank control group and negative control group were significantly lower than that in hsa-miR-205-3p group (P < 0.01),
indicating successful construction of MCF-7 cell lines with miR-205-3p overexpression (Figure 4 ).
| Effects of miR-205-3p on proliferation, invasion, and apoptosis of breast cancer cells
Effects of miR-205-3p on proliferation, invasion, and apoptosis of MCF-7 cells were detected via MTT assay, transwell assay, and flow cytometry, respectively. Results showed that both cell proliferation and invasion capacities in hsa-miR-205-3p group were significantly higher than those in blank control group and negative control group (P < 0.01, P < 0.01). After transfection with miR-205-3p, the number of apoptotic cells in hsa-miR-205-3p group was significantly decreased compared with those in the blank control group and negative control group (P < 0.01) ( Figure 5 ).
| Effects of miR-205-3p on related protein expressions
Ezrin, LaminA/C, cleaved caspase-3, Bcl-2, and Bax protein expressions in each group were detected via Western blotting. Results demonstrated that compared with those in the blank control group and negative control group, Ezrin, LaminA/C, and cleaved caspase-3 expressions were significantly declined in hsa-miR-205-3p group (P < 0.01), but the Bcl-2/Bax ratio was increased significantly (P < 0.01) ( Figure 6 ). F I G U R E 4 Detection of miR-205-3p expression after transfection by RT-qPCR. After MCF-7 cells were transfected with has-miR-205-3p, total RNA was isolated for analysis of the expression of miR-205-3p by RT-qPCR. The miR-205-3p expression level in cells in hsa-miR-205-3p group is significantly higher than those in blank control group and negative control group, ** P < 0.01
| D ISCUSS I ON
Breast cancer ranks first in the common malignant tumors in women, the current incidence of which accounts for more than 10% of the systemic tumors and seriously affects the physical health of women 19 Breast cancer occurs frequently in postmenopausal women mainly at the age of 45-65 years. With the environmental deterioration and other factors, a younger trend of breast cancer occurrence has been shown in recent years 20 The radical surgical resection, combined with radiotherapy and chemotherapy, marks the improvement regarding the survival time of early breast cancer patients, but its therapeutic effect is not satisfactory on advanced breast cancer patients 21 miRNA, as a kind of endogenous small noncoding RNA, plays an important role in cell differentiation, proliferation, and apoptosis through regulating the signaling pathway. Accumulative evidences indicate that a variety of miRNAs are involved in the regulation process of several tumors and play similar roles to tumor suppressor genes and oncogenes 22, 23 The abnormal expressions of miR-21 and miR-205 are possibly related to the occurrence and development of breast cancer 12 Li et al 24 found that the miR-205 expression level is increased in epithelial ovarian cancer, and is closely related to the proliferation and invasion of ovarian cancer. In this study, we found that the level of miR-205-3p was significantly upregulated in breast cancer tissues, and further in vitro assay by overexpressing miR-205-3p validated its role on proliferation, invasion, and apoptosis of cancer cells, which was in line with previous findings 24 .
Our data showed that Ezrin and LaminA/C protein expressions in MCF-7 cells with miR-205-3p overexpression were significantly decreased compared with those in normal cells, which was consistent with previous finding 25 Ezrin protein is an important protein molecule in the ERM protein family, which, as a connexin between cytoskeleton and cell membrane, plays an important regulatory role in cell movement and adhesion, cytoskeletal remodeling, etc Ezrin protein also exerts important effects on the occurrence and metastasis of tumors 26 It has been demonstrated that Ezrin functions as a prognostic factor and may predict potential lung metastasis in osteosarcoma and could also possibly be used as a new therapeutic target 27 Ezrin is closely linked with the metastatic progression of cancer and is required in tumor-induced angio/lymphangiogenesis in vivo, which is frequently abnormally expressed in aggressive cancer types 28 Interestingly, there is some controversy in the literature regarding the role of Ezrin in cancer metastasis and invasion. It has been indicated that the overexpression of Ezrin might promote ovarian cancer cell invasion and might predict poor prognosis 29 However, the study revealed that patients who had negative or low Ezrin expression had a significantly shorter survival than those whose tumors had moderate or high Ezrin expression, 30 which is consistent with our finding that Ezrin expressions were significantly declined in breast cancer tissues. Also, it has been shown that radixin, as a group are significantly higher than those in blank control group and negative control group, but the apoptosis level is obviously decreased, ** P < 0.01 methylation and histone deacetylation as a means to downregulate caveolin expression 32 The similar mechanisms may reduce ezrin expression, in addition to genetic alterations associated with breast carcinogenesis.
Expression of A-type lamins increases the risk of death from
colorectal cancer because its presence gives rise to increased invasiveness but not affect cell proliferation 33 By contrast, previous data indicate that low expression of lamin A/C is associated with an increased disease recurrence in stage II and III colon cancer patients 34 Moreover, evidence unraveled that cultured breast cancer cell lines expressed less lamin A/C compared with noncancerous mammary gland cells, which is in line with our result that LaminA/C was significantly decreased in breast cancer tissues 35 The loss of lamin A/C expression is associated with variables of poor prognosis and shorter outcome in patients with breast cancer 36 The loss of A-type lamins was shown to induce changes in nuclear distribution of telomeres and to affect telomere function, thereby inducing chromosomal instability 37 The malfunction of A-type lamins will increase chromosomal instability and stimulate carcinogenesis.
Increasing genomic instability may enhance tumor progression, Our data demonstrate that correlation of miR-205-3p with prognosis of breast cancer patients was established in those patients that died because the breast cancer but no other causes and miR-205-3p may serve as an important gene for prognosis evaluation of breast cancer. The limitation in our study still exists that the controversial result regarding the changes in Ezrin, LaminA/C in tumor tissues, and the potential mechanisms remain to be further investigated. We propose that cancer cells exhibit a variety of features indicative of atypical nuclei, while the changes in these indicators may be further related to tumor's pathological classification and cancer progression.
In conclusion, significantly higher miR-205-3p expression is found in breast cancer tissues and associated with shorter survival of patients. Highly expressed miR-205-3p promotes the proliferation and invasion and reduces the apoptosis of breast cancer cells in vitro, suggesting therapeutic targeting miR-205-3p might be a novel approach for the treatment of breast cancer.
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